STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
about
Neuroendocrine differentiation in prostate cancerSuppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancerNeuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinaseInterleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cellsThe role of obesity in gastrointestinal cancer: evidence and opinionNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureInterleukin-1beta-induced promatrilysin expression is mediated by NFkappaB-regulated synthesis of interleukin-6 in the prostate carcinoma cell line, LNCaPSustained proliferation in cancer: Mechanisms and novel therapeutic targetsAutophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cellsRANK-mediated signaling network and cancer metastasis.Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.Expression of basal cell keratins in human prostate cancer metastases and cell lines.Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.Stem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis.Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth.The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsSTAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers.Soluble interleukin-6 receptor to interleukin-6 (sIL‑6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomyNeuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.Clinical implications of neuroendocrine differentiation in prostate cancer.Stat3 promotes metastatic progression of prostate cancer.LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signalingInflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells.Genitourinary small-cell carcinoma: a single-institution experienceSTAT3 regulation of glioblastoma pathogenesis.Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.Molecular mechanisms of castration-resistant prostate cancer progression.Interleukin-6: a multifunctional targetable cytokine in human prostate cancer.Androgen receptor signaling in prostate cancer.The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.Proinflammatory cytokine interleukin-6 in prostate carcinogenesisIGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer.RhoGDIα suppresses growth and survival of prostate cancer cells.
P2860
Q24657547-E58ED2B9-EAB7-4D25-8ECB-B937ECC50302Q24677026-FC818C89-7056-4455-A84B-A41D6434B412Q24746249-58A5CB65-45AE-4BEC-B4EE-A981D8BD5362Q24746259-C3547C3A-A949-4892-B359-13562993BF8BQ24794588-91436DA8-E37B-46F4-B7A7-60B12AAB2DE0Q26825678-1E5899DD-7EBB-481F-9297-84D2A98103BCQ26859201-DFCC4B7E-9EB9-4C32-AD8A-D6FC27BA71B6Q28344474-A715BBE7-C862-44CD-8F82-789A88A730FBQ28396388-662210F8-9F0E-4CDE-999D-0B723E3F5F19Q28539820-2083EB78-5868-4EC3-8386-E80AC2EC1ECBQ30371052-B32BF608-076F-4EC2-A4E0-6A1F5775F4BAQ30432236-0FD0087E-8498-447B-9E7F-A12632BC4140Q31864260-1E926B40-9998-46EC-9FCA-BBA87BFDEC51Q32048563-6D1275F3-E168-4261-BE09-CABA3F8C1A6BQ33291100-D88AD712-65A3-4ED9-9BDE-D1A624CFBFD4Q33356928-88782718-C92E-4047-93B8-910B820C8757Q33724512-C458F4F2-E0C3-4A23-8AF8-2A0A3E2F3605Q34094656-F53CEA31-1E45-4541-86BF-A583AA953900Q34394076-53F9EF08-234B-4620-9634-0A6F54A5E8EAQ34714834-1CC8E0D1-55D1-4C91-A040-1B72C1CFFF34Q34811541-1090BBF8-320A-41CE-8CC1-893F6643103EQ35141115-B588DDB2-46CD-43BE-877E-833F01F79EE5Q35380936-92FFFE9D-2EDC-4B37-AA6F-0C76CE38990FQ35747457-72EF12F3-D882-479E-A354-D90EEA8B032CQ36126540-221ED9D5-A60E-4B43-9D9C-9CF8E786D3C8Q36233076-7B9AC8FC-B9C6-4F0A-AAF7-DD0D25B5C5CAQ36639877-5E80EB7A-3E69-49F1-B0FA-B0FED7105199Q36691140-D5D8D0F9-C1CE-491A-85FE-1D4C412314D8Q36879620-39E4A4CB-919A-4D27-859D-8F4497FFAD8BQ36940631-26B6075A-5BF9-482A-BE17-907A7A8DC314Q37247963-37A441BF-4E45-40B0-9FB9-5F43840D80AAQ37550760-1EB8C006-BD4F-4584-937F-ECEE13CCE27BQ37606662-E55E2D77-1EF8-405D-A878-EF2065885C3DQ37630578-22D78CAC-1306-4937-9776-3D497D672C85Q37888027-8F37A179-50BD-4133-80ED-0EDB4259F754Q38175320-2A025B1D-2018-4E2B-B1E3-7B025E806FC2Q38203779-AD013BCD-8AF7-448D-9ACD-854AF109704CQ38265575-72673A90-C8EC-4D3E-9967-541BFF3D6A25Q38290653-328641E0-491D-424E-BC38-EDAC5EAC5DA8Q38386536-1EB3AFCD-ABCD-4174-8199-5084E4321A93
P2860
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
@en
type
label
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
@en
prefLabel
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
@en
P2860
P1433
P1476
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E
P577
2000-02-01T00:00:00Z